Corrective gene transfer in the human skin disorder lamellar ichthyosis

Nature Medicine

Volumn 2, Issue 11, 1996, Pages 1263-1267

  Choate, Keith A ^a   Medalie, Dan A ^b   Morgan, Jeff R ^b   Khavari, Paul A ^a,c  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HUMAN; HUMAN CELL; KERATINOCYTE; LAMELLAR ICHTHYOSIS; MOUSE; PRIORITY JOURNAL; SKIN DISEASE;

3T3 CELLS; ANIMALS; CELL LINE; CELLS, CULTURED; GENE TRANSFER TECHNIQUES; HUMANS; ICHTHYOSIS, LAMELLAR; KERATINOCYTES; MICE; MICE, SCID; SKIN; TRANSGLUTAMINASES;

EID: 0029906097     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1196-1263     Document Type: Article

References (30)

1. Williams, M.L. & Elias, P.M. Genetically transmitted, generalized disorders of cornification. Dermatol. Clin. 5, 155-178 (1987).
2. Bale, S.J. & Doyle, S.Z. The genetics of ichthyosis: A primer for epidemiologists. J. Invest. Dermatol. 102, 49S-50S (1994).
3. Huber, M. et al. Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science 267, 525-528 (1995).
4. Russell, L.J. et al. Mutations in the gene for transglutaminase 1 in autosomal recessive lamellar ichthyosis. Nature Genet. 9, 279-283 (1995).
5. Khavari, P.A. et al. BRG1 contains a conserved domain of the SW12/SNF2 gene family necessary for normal mitotic growth and transcription. Nature 366, 170-174 (1993).
6. Gibson, D.F., Ratnam, A. V. & Bikle, D.D. Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J. Invest. Dermatol. 106, 154-161 (1996).
7. Gallico, G.G. et al. Permanent coverage of large burn wounds with autologous cultured human epithelium. N. Engl. J. Med. 311, 448 (1984).
8. Briggaman, R.A. Localization of the defect in skin diseases analyzed in the human skin graft-nude mouse model. Curr. Probl. Dermatol. 10, 115 (1980).
9. Kim, Y. et al. Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: Development of an experimental in vivo model. J. Invest. Dermatol. 98, 191-195 (1992).
10. Medalie, D.A. et al. Evaluation of human skin reconstituted from composite grafts of cultured keratinocytes and human acellular dermis transplanted to athymic mice. J. Invest. Dermatol. 107, 121-127 (1996).
11. Fenjves, E.S., Yao, S.-N., Kurachi, K. & Taichman, L.B. Loss of expression of a retrovirus-transduced gene in human keratinocytes. J. Invest. Dermatol. 106, 576-578 (1996).
12. Gerrard, A.J., Hudson, D.L., Brownlee, G.G. & Watt, F.M. Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genet. 3, 180-183 (1993).
13. Dale, B.A., Gown, A.M., Fleckman, M.D., Kimball, J.R. & Resing, K.A. Characterization of two monoclonal antibodies to human epidermal keratohyalin: Reactivity with filaggrin and related proteins. J. Invest. Dermatol. 88, 307-313 (1987).
14. Lavrijsen, A.P. et al. Barrier function parameters in various keratinization disorders: Transepidermal water loss and vascular response to hexyl nicotinate. Br. J. Dermatol. 129, 547-553 (1993).
15. Mancini, A.J., Sookdeo-Drost, S., Madison, K.C., Smoller, B.R. & Lane, A.T. Semipermeable dressings improve epidermal barrier function in premature infants. Pediatr. Res. 36, 306-314 (1994).
16. Garlick, J.A., Katz, A.B., Fenjves, E.S. & Taichman, L.B. Retrovirus-mediated transduction of cultured epidermal keratinocytes. J. Invest. Dermatol. 97, 824-829 (1991).
17. Kinsella, T.M. & Nolan, G.P. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413 (1996).
18. Roop, D. Defects in the barrier. Science 267, 474-475 (1995).
19. Ottey, K.A., Wood, L.C., Grunfeld, C., Elias, P.M. & Feingold, K.R. Cutaneous permeability barrier disruption increases fatty acid synthetic enzyme activity in the epidermis of hairless mice. J. Invest. Dermatol. 104, 401 (1995).
20. Taichman, L.B. Epithelial gene therapy, in The Keratinocyte Handbook, (eds. Leigh, I., Lane, B. & Watt, F.) 543-551 (Cambridge Univ. Press, 1994).
21. Greenhalgh, D.A., Rothnagel, J.A. & Roop, D.R. Epidermis: An attractive target tissue for gene therapy. J. Invest. Dermatol. 103S, 63S-69S (1994).
22. Vogel, J.C. Keratinocyte gene therapy. Arch. Dermatol. 129, 1478-1483 (1993).
23. Fenjves, E.S. Approaches to gene transfer in keratinocytes. J. Invest. Dermatol. 103, 70S-75S (1994).
24. Khavari, P.A. & Krueger, G.G. Cutaneous gene therapy. Dermatol. Clin. (in the press).
25. Rheinwald, J.G. & Green, H. Serial cultivation of strains of human epidermal keratinocytes. Cell, 6, 331 (1975).
26. Thacher, S.M. & Rice, R.H. Keratinocyte-specific transglutaminase of cultured human epidermal cells: Relation to cross-linked envelope formation and terminal differentiation. Cell 40, 685-695 (1985).
27. Ta, B.M., Gallagher, G.T., Chakravarty, R. & Rice, R.H. Keratinocyte transglutaminase in human skin and oral mucosa: Cytoplasmic localization and uncoupling of differentiation markers. J. Cell Sci. 95, 631 (1990).
28. Murphy, G.F., Flynn, T.C., Rice, R.H. & Pinkus, G.S. Involucrin expression in normal and neoplastic human skin: A marker for keratinocyte differentiation. J. Invest. Dermatol. 82, 453-457 (1984).
29. Ivanyi, D. et al. New monoclonal antibodies recognizing epidermal differentiation-associated keratins in formalin-fixed, paraffin embedded tissue: Keratin 10 expression in carcinoma of the yulva. J. Pathol. 159, 7-12 (1989).
30. Roop, D.R. et al. Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. J. Biol. Chem. 259, 8037-8040 (1984).